Bayer: Dysmenorrhea trials

The registry lists 11 Dysmenorrhea studies with Bayer as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 2Phase 3 6Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess Menstrual Cramp Pain Associated With Primary DysmenorrheaCompletedNCT03448536Phase 4Results posted
• Effect on Primary DysmenorrheaCompletedNCT00909857Phase 3Results posted
• SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative StudyCompletedNCT00511797Phase 2/3Results posted
• Safety Study of Ethinylestradiol/Drospirenone in DysmenorrheaCompletedNCT00461305Phase 2/3Results posted
• Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in JapanCompletedNCT04607382
• Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or DysmenorrheaCompletedNCT03126747
• To Investigate Efficacy of YAZ in the Treatment of DysmenorrheaWithdrawnNCT02617537Phase 3
• Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and DysmenorrheaCompletedNCT02475356
• Comparative Study of BAY86-5300 With a Flexible Extended Regimen for DysmenorrheaCompletedNCT01892904Phase 3
• YAZ Post-marketing Surveillance in JapanCompletedNCT01375998
• SH T00186 in the Treatment of Primary DysmenorrheaCompletedNCT00569244Phase 3